ArticleJournal of hepatocellular carcinoma2026
Post-TARE Survival Outcomes in Hepatocellular Carcinoma: Influence of Pre-TARE Immunotherapy and Targeted Therapy in a Real-World Cohort.
Xiao-Yong Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.